{"DataElement":{"publicId":"7197073","version":"1","preferredName":"Subcategory of Drug Accountability Assessment","preferredDefinition":"A sub-division of the DACAT values based on sponsor defined characteristics.","longName":"DA_DASCAT_RETAMT_SPD","context":"NRDS","contextVersion":"1","DataElementConcept":{"publicId":"6413070","version":"1","preferredName":"Drug Accountability Domain Returned Amount Drug Accountability Record Subcategorization","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to drug accountability._The quantity of a product that has been returned._A sub-division of the drug accountability classification.","longName":"6407461v1.0:6413068v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6407461","version":"1","preferredName":"Drug Accountability Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to drug accountability.","longName":"C49578","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Product Accountability Domain","conceptCode":"C49578","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to drug and other product accountability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F3E4F1-2F42-2B37-E053-F662850AC5F2","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6413068","version":"1","preferredName":"Returned Amount Drug Accountability Record Subcategorization","preferredDefinition":"The quantity of a product that has been returned.:A sub-division of the drug accountability classification.","longName":"C78722:C83141","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Returned Amount","conceptCode":"C78722","definition":"The quantity of a product that has been returned.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Drug Accountability Record Subcategorization","conceptCode":"C83141","definition":"A sub-division of the drug accountability classification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74364DD4-0258-5948-E053-F662850ADFEA","latestVersionIndicator":"Yes","beginDate":"2018-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-24","modifiedBy":"ONEDATA","dateModified":"2018-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"74364DD4-0269-5948-E053-F662850ADFEA","latestVersionIndicator":"Yes","beginDate":"2018-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-24","modifiedBy":"KUMMEROA","dateModified":"2021-06-09","changeDescription":"2021-6-9 ak Released per governance approval.; Created as part of the CDISC mapping task_ghd_08.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7185248","version":"1","preferredName":"Returned Amount Drug Accountability Record Subcategorization Clinical Study Sponsor Defined Name","preferredDefinition":"A sub-division of the drug accountability classification._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._The words or language units by which a thing is known.","longName":"DASCAT_RETAMT_SPD","context":"NRDS","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"OTHER","valueDescription":"Other","ValueMeaning":{"publicId":"5697874","version":"1","preferredName":"Other","longName":"5697874","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A253837-4DE2-5542-E053-F662850A338C","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-03-07","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F67CFE7-CAA6-3920-E053-F662850A959B","beginDate":"2020-02-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-25","modifiedBy":"ONEDATA","dateModified":"2020-02-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7185247","version":"1","preferredName":"Returned Amount Drug Accountability Record Subcategorization Clinical Study Sponsor Defined Name","preferredDefinition":"The quantity of a product that has been returned.:A sub-division of the drug accountability classification.:An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]:Clearly characterized or delimited.:The words or language units by which a thing is known.","longName":"7185247v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Returned Amount","conceptCode":"C78722","definition":"The quantity of a product that has been returned.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Drug Accountability Record Subcategorization","conceptCode":"C83141","definition":"A sub-division of the drug accountability classification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Sponsor","conceptCode":"C70793","definition":"An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Defined","conceptCode":"C165683","definition":"Clearly characterized or delimited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F67CFE7-CA7F-3920-E053-F662850A959B","latestVersionIndicator":"Yes","beginDate":"2020-02-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-25","modifiedBy":"ONEDATA","dateModified":"2020-02-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9F67CFE7-CA90-3920-E053-F662850A959B","latestVersionIndicator":"Yes","beginDate":"2020-02-25","endDate":"2022-07-12","createdBy":"TAYLORT","dateCreated":"2020-02-25","modifiedBy":"GDEEN","dateModified":"2022-07-14","changeDescription":"2/25/20 Created to support sponsor defined codelists; tmt.","administrativeNotes":"07.14.22_Released during quarterly metrics and per request from G. Riley_ghd","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5858962","version":"1","longName":"Under Review","context":"NRDS","ClassificationSchemeItems":[{"publicId":"7066596","version":"1","longName":"CDISC (NRDS Implementation)","context":"NRDS"},{"publicId":"7067375","version":"1","longName":"Sponsor Defined","context":"NRDS"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"What was the name of the trea","type":"Preferred Question Text","description":"What was the name of the treatment returned?","url":null,"context":"NRDS"},{"name":"CDASH PROMPT","type":"Alternate Question Text","description":"Treatment Name","url":null,"context":"NRDS"},{"name":"CDASH Implementation Notes","type":"CDASH Implementation Note","description":"Sponsor-defined Controlled Terminology. This would most commonly be either a heading, or a pre-printed category value on the CRF and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as \"Subcategory\" can be included as the column header If it is known at the time of data collection, the treatment name may be collected in DASCAT (with appropriate, but different than DACAT, grouping values). See SDTMIG V3.2 section 6.3.8.2.for examples on populating DACAT and DASCAT. DASCAT can only be used if there is an DACAT and it must be a subcategorization of DACAT. This CDASH variable name is an example of what \"variable name\" can be used in a denormalized data structure.","url":null,"context":"NRDS"},{"name":"DASCAT","type":"CDASH to SDTM Mapping","description":"Maps directly to the SDTMIG variable.","url":null,"context":"NRDS"},{"name":"Case Report Form Completion Instructions","type":"CDISC CRF Instruction","description":"Record the name of the study treatment returned (e.g., DRUG A, DRUG B, BOTTLE 1).","url":null,"context":"NRDS"}],"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A06DC1C9-952A-48C1-E053-F662850ABEA3","latestVersionIndicator":"Yes","beginDate":"2020-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-03-09","modifiedBy":"GDEEN","dateModified":"2022-07-14","changeDescription":"3-9-20 tmt created for sponsor-defined codelists.","administrativeNotes":"07.14.22_Released as part of the quarterly metrics and per request of G. Riley_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}